Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Gene Expression Profiling Predicts Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Catherine M Claussen, MS, Hans Lee, MD, Jatin J. Shah, MD, Tiffany Richards, ANP, Nina Shah, MD, Krina Patel, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Sheeba Thomas, MD, Yago Nieto, MD PhD, Muzaffar H. Qazilbash, MD, Richard Eric Davis, MD, Sattva S. Neelapu, MD, Donna M. Weber, MD, Robert Z. Orlowski, PhD, MD, Lei Feng, MS, Elisabet E. Manasanch, MD

Blood (2016) 128 (22): 5628.

https://doi.org/10.1182/blood.V128.22.5628.5628

Published: 2016

Journal Articles

Outcome of Autologous Stem Cell Transplantation in Myeloma Patients Aged ≥ 75 Years

Qaiser Bashir, MD, Mohammed El Shazly, Denái R. Milton, Krina Patel, MD, Nina Shah, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Uday R. Popat, MD, Simrit Parmar, MD, Betul Oran, MD, Stefan O. Ciurea, MD, Chitra Hosing, MD, Hans Lee, MD, Elisabet E. Manasanch, MD, Robert Z. Orlowski, PhD, MD, Richard E. Champlin, MD, Muzaffar Qazilbash, MD

Blood (2016) 128 (22): 3453.

https://doi.org/10.1182/blood.V128.22.3453.3453

Published: 2016

Journal Articles

The Anti-Tumor Effect of the Ubiquitin-Activating Enzyme (UAE) Inhibitor TAK-243 on Pre-Clinical Models of Multiple Myeloma

Junling Zhuang, MD PhD, Hans Lee, MD, Isere Kuiatse, PhD, Hua Wang, PhD, Fazal Shirazi, PhD, Allison Berger, PhD, Marc Hyer, PhD, Nibedita Chattopadhyay, PhD, Sakeena Syed, Judy Qiuju Shi, Jie Yu, M.S., Vaishali Shinde, Anna Kreshock, Stephen Tirrell, PhD, Saurabh Menon, PhD, Richard Julian Jones, PhD, Robert Z. Orlowski, MD PhD

Blood (2016) 128 (22): 3296.

https://doi.org/10.1182/blood.V128.22.3296.3296

Published: 2016

Journal Articles

Outcome of Autologous Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Multiple Myeloma

Lauren Westfall Veltri, MD, Denái R. Milton, Nina Shah, MD, Krina Patel, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Uday R. Popat, MD, Simrit Parmar, MD, Betul Oran, MD, Stefan O. Ciurea, MD, Chitra Hosing, MD, Hans Lee, MD, Elisabet E. Manasanch, MD, Robert Z. Orlowski, PhD, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD

Blood (2016) 128 (22): 4626.

https://doi.org/10.1182/blood.V128.22.4626.4626

Published: 2016

Journal Articles

RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma

Hans Lee, MD, Hua Wang, PhD, Heather Lin, M.S., Veera Baladandayuthapani, PhD, Jin He, Richard Julian Jones, PhD, Isere Kuiatse, PhD, Dongmin Gu, MD, PhD, Zhiqiang Wang, PhD, Sean O'Brien, PhD, Jonathan J Keats, PhD, Jing Yang, PhD, Richard Eric Davis, MD, Robert Z. Orlowski, PhD, MD

Blood (2015) 126 (23): 3010.

https://doi.org/10.1182/blood.V126.23.3010.3010

Published: 2015

Journal Articles

Use of Gene Expression Profiling May Predict Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Catherine M Claussen, MS, Tammy Chuang, Jatin Shah, MD, Hans Lee, MD, Nina Shah, MD, Krina K Patel, Qaiser Bashir, MD, Simrit Parmar, MD, Sheeba Thomas, MD, Muzaffar Qazilbash, MD, Richard Eric Davis, MD, Sattva S. Neelapu, MD, Donna Weber, MD, Robert Z. Orlowski, PhD, MD, Lei Feng, MS, Elisabet E. Manasanch, MD

Blood (2015) 126 (23): 5390.

https://doi.org/10.1182/blood.V126.23.5390.5390

Published: 2015

Journal Articles

ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response

Blood (2015) 126 (23): 2051.

https://doi.org/10.1182/blood.V126.23.2051.2051

Published: 2015

NARROW

Gene Expression Profiling Predicts Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Outcome of Autologous Stem Cell Transplantation in Myeloma Patients Aged ≥ 75 Years

The Anti-Tumor Effect of the Ubiquitin-Activating Enzyme (UAE) Inhibitor TAK-243 on Pre-Clinical Models of Multiple Myeloma

Outcome of Autologous Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Multiple Myeloma

RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma

Use of Gene Expression Profiling May Predict Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response

Email alerts

ASH Publications

American Society of Hematology

Gene Expression Profiling Predicts Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

Outcome of Autologous Stem Cell Transplantation in Myeloma Patients Aged ≥ 75 Years

The Anti-Tumor Effect of the Ubiquitin-Activating Enzyme (UAE) Inhibitor TAK-243 on Pre-Clinical Models of Multiple Myeloma

Outcome of Autologous Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Multiple Myeloma

RNA Polymerase I Inhibition with CX-5461 As a Novel Strategy to Target MYC in Multiple Myeloma

Use of Gene Expression Profiling May Predict Clinical Outcomes in Newly Diagnosed Multiple Myeloma Patients in a Standard of Care Setting

ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only